Saturday, November 2, 2024
Home Tags Contributor Profile

Contributor Profile Related News

sphingotec to launch biomarkers addressing unmet medical need

sphingotec to launch biomarkers addressing unmet medical need

sphingotec GmbH is set to launch first-in-class blood biomarker point-of-care tests that allow early diagnosis and monitoring of disorders caused by acute kidney dysfunction...
The immune landscape of breast cancer

The immune landscape of breast cancer

At the University of Turku, Maija Hollmén, PhD, is helping to elucidate the significance of macrophage-expressed Clever-1 in defining the immune cell composition in...
Platome Biotechnology – advancing cellular therapies

Platome Biotechnology – advancing cellular therapies

Icelandic company Platome Biotechnology is reinventing cell culture to help speed up the development of approved cellular therapies. Regenerative medicine will play a key role...
The timing of immunotherapy

The timing of immunotherapy

The Departments of Surgery and Molecular Cell Biology & Immunology, VU University Medical Center, Amsterdam, explore how immunotherapy can be used to fight against...
Thula – Nordic Source Solutions

Thula – Nordic Source Solutions

Thula-Nordic Source Solutions explains how it is taking charge of medicine management through innovative technologies. Thula-Nordic Source Solutions is a dynamic software product development and consulting...
Increased safety in treatment of urethra strictures, thanks to tissue engineering

Increased safety in treatment of urethra strictures, thanks to tissue engineering

Biotechnology saves patients from excision of large pieces of native oral mucosa transplants for the plastic reconstruction of morbidly constricted urethras. About one percent of...
Seeing is believing: the need for in vivo imaging in cell therapies

Seeing is believing: the need for in vivo imaging in cell therapies

Dr Mangala Srinivas, from the Multiscale Imaging Lab, discusses some of the challenges facing cell therapies and how they might be overcome. Cell therapy’ –...
The past, present and future of Wageningen Bioveterinary Research

The past, present and future of Wageningen Bioveterinary Research

Dr Riks Maas and Professor Jeroen Kortekaas discuss the pioneering work of Wageningen Bioveterinary Research in the fields of viral vaccine development and animal...
Evolution of regional anesthesia and postoperative pain relief

Evolution of regional anesthesia and postoperative pain relief

Dr Sermeus of the Department of Anesthesia, Antwerp University Hospital, explores the evolution of regional anesthesia and the impact of technology on its development. Since...
Bar-Ilan University: a habitat for interdisciplinary science

Bar-Ilan University: a habitat for interdisciplinary science

Professor Shulamit Michaeli presents Bar-Ilan University, a Tel Aviv-based university boasting big ambitions, unparalleled achievements, and ever-increasing academic prowess. Bar-Ilan University (BIU), located in the...
Neuroscience Trials Australia – leading the way in clinical trials

Neuroscience Trials Australia – leading the way in clinical trials

Why Australia is undoubtably the place to be for conducting clinical trials in the neuroscience space. Neuroscience Trials Australia is an Australian-based, niche, not-for-profit contract...
Breaking tolerance: improving cancer immunotherapy

Breaking tolerance: improving cancer immunotherapy

The group of Dr Maija Hollmén at Turku University, Finland, attempts to make cold tumours hot by targeting the tumour-supporting functions of innate immune...
Getting to the heart of the matter: can we prevent cardiovascular disease?

Getting to the heart of the matter: can we prevent cardiovascular disease?

The dramatic increase in age-associated disorders such as cardiovascular disease represents a major burden on modern society. Researchers at the University of Leuven, Belgium,...
Welcome to the Kuopio Center for Gene and Cell Therapy

Welcome to the Kuopio Center for Gene and Cell Therapy

The Kuopio Center for Gene and Cell Therapy is home to the research and development of new innovative medicines. The Kuopio Center for Gene and...
Mapping immune signalling

Mapping immune signalling

Anders Linden on the mapping of immune signalling via the cytokine interleukin-26 to identify novel diagnostic and therapeutic targets in COPD. In the research group...
AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney disease

AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney...

The high and increasing unmet patient need in diabetic kidney disease demands new drugs. Betagenon AB has the answer. Globally, approximately 40% of Type 2...
The psychiatric patient and the ED - the evolution of emergency psychiatry

The psychiatric patient and the ED

Marc Sabbe discusses the evolution of emergency psychiatry, highlighting issues such as deinstitutionalisation and cost containment. There is no doubt that the amount and intensity...
STOP-CP: Stem cell Treatment Of Perinatal Cerebral Palsy using cord blood

STOP-CP in children – Stem cell Treatment Of Perinatal Cerebral Palsy using cord blood

Arne Jensen, CEO of BrainRepair UG and head of the Campus Clinic Gynaecology Bochum, Germany, outlines the motivation behind STOP-CP!: Stem cell Treatment Of...

Pin It on Pinterest